We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CVS Health's Aetna Advances Initiative to Curb Hospital Readmissions
Read MoreHide Full Article
Key Takeaways
CVS' Aetna is expanding its Clinical Collaboration program to 10 hospitals by the end of 2025.
The initiative embeds CVS Aetna nurses to support Medicare Advantage members after discharge.
CVS drives Aetna's margin recovery while using AI and streamlining cancer care approvals.
CVS Health’s (CVS - Free Report) insurance arm, Aetna, has announced that it is expanding the Aetna Clinical Collaboration (“ACC”) program to 10 hospitals by the end of 2025. The initiative embeds Aetna nurses within hospitals to help Medicare Advantage members get the care and support they need to remain healthy after leaving the hospital or transitioning into a skilled nursing facility. Implementations are already underway with AdventHealth Shawnee Mission, Houston Methodist and WakeMed Health & Hospitals.
Reducing preventable hospital readmissions has long been a top priority for payers, providers, and policymakers aiming to improve healthcare outcomes and control costs.Re-admissions are more frequent among older populations, with nearly 20% Medicare-insured patients who are hospitalized being readmitted within 30 days of discharge. Aetna launched the first ACC program earlier this year, with roughly one in four program members already actively engaged with an Aetna care manager.
With more than 4 million members over 65, Aetna plans to expand the ACC program across its network in 2026 and beyond. Once fully implemented at scale, the program is expected to reduce 30-day readmissions and hospital length of stay by 5% year over year. Apart from lowering the 30-day readmission rates and emergency room visits, the ACC program also eases the administrative load on hospitals and clinical staff. Aetna is implementing the program for its Commercial business as well.
Meanwhile, CVS Health’s strong execution is helping Aetna restore its target margins. At the same time, the company continues to drive innovation to simplify health care, such as streamlining the prior authorization process in certain areas of cancer care, as well as introducing Aetna Care Paths and AI-driven programs as part of its ongoing technology investments.
Updates From CVS Health’s Competitors
Humana (HUM - Free Report) recently announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2026. All Humana non-special needs Medicare Advantage plans include dental, vision and hearing coverage, zero copays for covered preventive dental services and in-network preventive services. Furthermore, preventive and diagnostic screenings for breast cancer, colon cancer and bone density are now included in the Medicare Advantage plans at no additional cost to members. In 2026, Humana will have Medicare Advantage plan offerings in 46 states and Washington, D.C., covering 85% of U.S. counties.
Centene Corp.’s (CNC - Free Report) subsidiary,WellCare of North Carolina (WellCare), is investing more than $1.6 million in local nonprofit organizations to support community health across North Carolina. This funding, which began in 2024 and will continue throughout this year, will help support critical healthcare needs such as assisting with food and nutrition, clothing, utilities, housing and interpersonal safety for the state’s most vulnerable citizens, including families and children.
CVS Stock Performance, Valuation and Estimates
In the past three months, CVS Health shares have risen 17.3% compared with the industry’s 2% growth.
Image Source: Zacks Investment Research
CVS Health is trading at a forward five-year sales multiple of 0.24, lower than the industry average of 0.40.
Image Source: Zacks Investment Research
See how the analysts are projecting CVS’ 2025 and 2026 earnings.
Image: Bigstock
CVS Health's Aetna Advances Initiative to Curb Hospital Readmissions
Key Takeaways
CVS Health’s (CVS - Free Report) insurance arm, Aetna, has announced that it is expanding the Aetna Clinical Collaboration (“ACC”) program to 10 hospitals by the end of 2025. The initiative embeds Aetna nurses within hospitals to help Medicare Advantage members get the care and support they need to remain healthy after leaving the hospital or transitioning into a skilled nursing facility. Implementations are already underway with AdventHealth Shawnee Mission, Houston Methodist and WakeMed Health & Hospitals.
Reducing preventable hospital readmissions has long been a top priority for payers, providers, and policymakers aiming to improve healthcare outcomes and control costs.Re-admissions are more frequent among older populations, with nearly 20% Medicare-insured patients who are hospitalized being readmitted within 30 days of discharge. Aetna launched the first ACC program earlier this year, with roughly one in four program members already actively engaged with an Aetna care manager.
With more than 4 million members over 65, Aetna plans to expand the ACC program across its network in 2026 and beyond. Once fully implemented at scale, the program is expected to reduce 30-day readmissions and hospital length of stay by 5% year over year. Apart from lowering the 30-day readmission rates and emergency room visits, the ACC program also eases the administrative load on hospitals and clinical staff. Aetna is implementing the program for its Commercial business as well.
Meanwhile, CVS Health’s strong execution is helping Aetna restore its target margins. At the same time, the company continues to drive innovation to simplify health care, such as streamlining the prior authorization process in certain areas of cancer care, as well as introducing Aetna Care Paths and AI-driven programs as part of its ongoing technology investments.
Updates From CVS Health’s Competitors
Humana (HUM - Free Report) recently announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2026. All Humana non-special needs Medicare Advantage plans include dental, vision and hearing coverage, zero copays for covered preventive dental services and in-network preventive services. Furthermore, preventive and diagnostic screenings for breast cancer, colon cancer and bone density are now included in the Medicare Advantage plans at no additional cost to members. In 2026, Humana will have Medicare Advantage plan offerings in 46 states and Washington, D.C., covering 85% of U.S. counties.
Centene Corp.’s (CNC - Free Report) subsidiary,WellCare of North Carolina (WellCare), is investing more than $1.6 million in local nonprofit organizations to support community health across North Carolina. This funding, which began in 2024 and will continue throughout this year, will help support critical healthcare needs such as assisting with food and nutrition, clothing, utilities, housing and interpersonal safety for the state’s most vulnerable citizens, including families and children.
CVS Stock Performance, Valuation and Estimates
In the past three months, CVS Health shares have risen 17.3% compared with the industry’s 2% growth.
Image Source: Zacks Investment Research
CVS Health is trading at a forward five-year sales multiple of 0.24, lower than the industry average of 0.40.
Image Source: Zacks Investment Research
See how the analysts are projecting CVS’ 2025 and 2026 earnings.
Image Source: Zacks Investment Research
CVS currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.